Freska buys Oceanside avocado packing plant
Agribusiness, Latest news, Top Stories, Tri-County Public CompaniesOxnard-based Freska Produce International has purchased an avocado packer, Harvest Time Produce of Oceanside, the company announced in a news release Dec. 17. The move by Freska, which already has a Mexican avocado program, will allow the company known for mangoes to use the Oceanside packing plant to become a year-round provider of avocados. Terms Read More →
Amgen increases dividend to $1 per share
Health Care & Life Science, Latest news, Tri-County Public CompaniesAmgen increased its yearly dividend 27 percent this year to $1 per share. Previously, the dividend had been 79 cents per share for the Thousand Oaks-based biotech giant. Shares jumped after news of the 27-cent dividend broke. The announcement was made just after the markets closed at 1:11 p.m. Amgen closed the trading day up Read More →
Ceres plans to raise $6.7 million through public stock offering Dec. 17
Agribusiness, Latest news, Tri-County Public CompaniesCeres, a Thousand Oaks-based agriculture-biotechnology company, priced shares at 40 cents each on Dec. 15 for its follow-on public offering on Dec. 17. Ceres plans to raise $6.7 million through the offering, which will be comprised of 600,000 shares of common stock, 6,460 shares of preferred stock convertible into 16,150,000 shares of common stock, and Read More →
CPUC approves Frontier takeover of Verizon subscribers
Latest newsThe California Public Utilities Commission approved on Dec. 4 Frontier Communications’ application to buy all Internet, TV and landline phone subscribers in California from Verizon Communications. Norwalk, Conn.-based Frontier agreed in February to pay Verizon $10.5 billion for all Internet, TV and phone subscribers in California, Texas and Florida. The Federal Communications Commission approved the Read More →
Novartis biosimilar works as well as Amgen’s Neulasta
Health Care & Life Science, Latest news, Tri-County Public CompaniesSwiss pharmaceutical Novartis announced Monday that a copycat version of Amgen’s Neulasta works just as well to prevent a condition that can lead to infection in women with breast cancer. Neulasta stimulates white blood cell production in the body, which helps the body fight cancer. Novartis’ new drug is part of a new class of Read More →
